Daryl C Pope

Array ( [id] => 1196963 [patent_doc_number] => 06727235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Synergistic compositions for the selective control of tumor tissue' [patent_app_type] => B2 [patent_app_number] => 10/371088 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5069 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727235.pdf [firstpage_image] =>[orig_patent_app_number] => 10371088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246072 [patent_doc_number] => 06677370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Compositions and uses of dictyostatin compounds' [patent_app_type] => B2 [patent_app_number] => 10/360200 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6894 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677370.pdf [firstpage_image] =>[orig_patent_app_number] => 10360200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674865 [patent_doc_number] => 20030060468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => '2,3,4,4a-Tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivatives' [patent_app_type] => new [patent_app_number] => 10/244773 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11022 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060468.pdf [firstpage_image] =>[orig_patent_app_number] => 10244773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231741 [patent_doc_number] => 06693104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Theobromine with an anti-carcinogenic activity' [patent_app_type] => B2 [patent_app_number] => 10/223104 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3969 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693104.pdf [firstpage_image] =>[orig_patent_app_number] => 10223104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228517 [patent_doc_number] => 06696428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Use of dopamine receptor antagonists in palliative tumor therapy' [patent_app_type] => B2 [patent_app_number] => 10/210881 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 1489 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696428.pdf [firstpage_image] =>[orig_patent_app_number] => 10210881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329159 [patent_doc_number] => 20020198153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Method of enhancing the efficacy of anti-tumor agents' [patent_app_type] => new [patent_app_number] => 10/206533 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4632 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198153.pdf [firstpage_image] =>[orig_patent_app_number] => 10206533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537796 [patent_doc_number] => 20020193391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects' [patent_app_type] => new [patent_app_number] => 10/171691 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11225 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193391.pdf [firstpage_image] =>[orig_patent_app_number] => 10171691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538428 [patent_doc_number] => 20020193434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Anti-tumor composition' [patent_app_type] => new [patent_app_number] => 10/156105 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6210 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193434.pdf [firstpage_image] =>[orig_patent_app_number] => 10156105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653603 [patent_doc_number] => 20030008923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Antineoplastic combinations' [patent_app_type] => new [patent_app_number] => 10/157656 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5752 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008923.pdf [firstpage_image] =>[orig_patent_app_number] => 10157656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625457 [patent_doc_number] => 06723712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Antiviral agent for use in treatment of cancer' [patent_app_type] => B2 [patent_app_number] => 10/138999 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7872 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723712.pdf [firstpage_image] =>[orig_patent_app_number] => 10138999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303839 [patent_doc_number] => 06620834 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Medicinal compositions for treating colorectal cancer' [patent_app_type] => B1 [patent_app_number] => 10/019469 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3044 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620834.pdf [firstpage_image] =>[orig_patent_app_number] => 10019469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329407 [patent_doc_number] => 20020198183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Treatment of cancer with thymidine in combination with temozolamide' [patent_app_type] => new [patent_app_number] => 10/114291 [patent_app_country] => US [patent_app_date] => 2002-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1378 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198183.pdf [firstpage_image] =>[orig_patent_app_number] => 10114291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348555 [patent_doc_number] => 06579877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-17 [patent_title] => 'Combination of benzoquinazoline antifolates and protecting agents' [patent_app_type] => B2 [patent_app_number] => 10/100582 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7503 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579877.pdf [firstpage_image] =>[orig_patent_app_number] => 10100582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159101 [patent_doc_number] => 20020147213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative' [patent_app_type] => new [patent_app_number] => 10/084183 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5907 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147213.pdf [firstpage_image] =>[orig_patent_app_number] => 10084183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363754 [patent_doc_number] => 06569877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-27 [patent_title] => 'Therapeutic and prophylactic agents for neoplasms' [patent_app_type] => B2 [patent_app_number] => 10/053136 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6231 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 385 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569877.pdf [firstpage_image] =>[orig_patent_app_number] => 10053136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1300387 [patent_doc_number] => 06624170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'Method for treating cancer with water-insoluble S-Camptothecin of the closed lactone ring form and derivatives thereof' [patent_app_type] => B2 [patent_app_number] => 10/052294 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 6344 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624170.pdf [firstpage_image] =>[orig_patent_app_number] => 10052294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658421 [patent_doc_number] => 20030133994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'METHOD FOR TREATING CANCER HAVING GREATER EFFICACY AND REDUCED ADVERSE EFFECTS' [patent_app_type] => new [patent_app_number] => 10/044575 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2661 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133994.pdf [firstpage_image] =>[orig_patent_app_number] => 10044575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261881 [patent_doc_number] => 06664285 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Use of cell membrane penetrating indigoid bisindole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/958674 [patent_app_country] => US [patent_app_date] => 2002-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4594 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664285.pdf [firstpage_image] =>[orig_patent_app_number] => 09958674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969114 [patent_doc_number] => 20020091132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/032489 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3127 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091132.pdf [firstpage_image] =>[orig_patent_app_number] => 10032489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669482 [patent_doc_number] => 20030114466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Inhibiting T-cell proliferation' [patent_app_type] => new [patent_app_number] => 10/016108 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3020 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114466.pdf [firstpage_image] =>[orig_patent_app_number] => 10016108 [rel_patent_id] =>[rel_patent_doc_number] =>)